World's First Cardiac Adult Stem Cell Patient and Physicians Discuss Clinical Trial

Friday, September 18, 2009 General News
Email Print This Page Comment bookmark
Font : A-A+



Infusion Procedure Performed on July 17th

LOUISVILLE, Ky., July 23 /PRNewswire-USNewswire/ -- University of Louisville physicians performed the world's first cardiac adult stem cell infusion procedure at Jewish Hospital in Louisville, KY, on July 17, 2009. The procedure is part of the first FDA-approved clinical trial using adult cardiac stem cells to treat heart disease.

The first patient, along with clinical study leader Roberto Bolli, Jewish Hospital Heart and Lung Institute Distinguished Chair in Cardiology and Director of UofL's Institute for Molecular Cardiology, and Mark Slaughter, M.D., Chief of the Division of Cardiothoracic Surgery at UofL and Director of the Heart Transplant and Mechanical Assist Device Program at Jewish Hospital, will speak at a news briefing on Friday, July 24 at 9:30 a.m. (EDT). The location is the Jewish Hospital Heart & Lung Center, Hank Wagner Conference Center (CC) located at 201 Abraham Flexner Way in Louisville, KY.

The news briefing along with b-roll will be uplinked via satellite from 12-1 p.m. (EDT) the same day at the following coordinates:

C-band AMC 6 Transponder 21

Uplink Frequency 6345 Horizontal

Downlink Frequency 4120 Vertical

B-roll and photography will also be provided at the news briefing.

SOURCE Jewish Hospital


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook